Tango’s pancreatic cancer combo shows striking promise at ESMO, building on Revolution Medicines’ earlier success
read at STAT ↗Positive readoutPositive
Tango presented new data on its pancreatic cancer combination at the opening of the ESMO conference, highlighting a striking level of activity that builds on earlier success reported by Revolution Medicines.
The session also included early release of detailed results for cancer vaccine programs from Moderna and Merck, offering additional insights into the evolving immunotherapy landscape.
In related biotech news, Star Therapeutics announced a fundraising round, while investors reacted negatively to Moderna’s stock following the vaccine data release.
source
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Tango builds on Revolution Medicines’ pancreatic cancer success”
read at STAT ↗444 words · retrieved 1h ago
comments(0)
5-min edit window · permanent after that